ArticleBlood advances2025

Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.

Meira Yisraeli Salman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.